Stocks
203316PRXL
YHDHealthcareBiotechnology$88.08-0.02%
Price as of · delayed, not real-time
A leading provider of biopharmaceutical services, specializing in clinical research and consulting for the life sciences industry. Investors monitor its performance as a bellwether for contract research organization (CRO) sector health.
Market Cap: $052W Range: $51.16-$88.10
Congressional Interest in 203316 (PRXL)
4 members of Congress have disclosed 23 trades in 203316 (PRXL), a Healthcare company. The buy/sell breakdown shows 14 purchases versus 9 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
23
Unique Politicians
4
Buys
14
Sells
9
Who in Congress Is Trading PRXL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-08-23 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2017-04-17 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2017-04-05 | Carlos Curbelo | sell | $1K-$15K |
| 2016-12-30 | Carlos Curbelo | buy | $1K-$15K |
| 2016-12-21 | Pete Sessions | sell | $15K-$50K |
| 2015-12-18 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2015-08-31 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2015-08-06 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2015-08-04 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2011-07-12 | MICHAEL T. MCCAUL | buy | $15K-$50K |
| 2011-07-07 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2011-07-06 | MICHAEL T. MCCAUL | buy | $15K-$50K |
| 2011-03-08 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2011-03-05 | MICHAEL T. MCCAUL | buy | $15K-$50K |
| 2011-03-05 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2011-03-03 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2011-03-02 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2010-09-02 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2008-10-03 | ZOE LOFGREN | sell | $1K-$15K |
| 2008-06-10 | MICHAEL T. MCCAUL | buy | — |
| 2008-06-10 | MICHAEL T. MCCAUL | buy | — |
| 2008-04-11 | MICHAEL T. MCCAUL | buy | — |
| 2008-04-11 | MICHAEL T. MCCAUL | buy | — |